Recent Posts

$4 Million Awarded In 1st Pa. Trial Alleging Birth Defect From Topamax Epilepsy Drug
Posted on 31 Oct 2013 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania jury on Oct. 30 found that Janssen Pharmaceuticals Inc. failed to warn about the risk of birth defects from its Topamax epilepsy drug and awarded the injured minor $4 million in damages (April Czimmer... Read More